Tradestie Institutional Equity Comparison Engine

SYK vs PHG โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SYK Overall Edge

SYK Captures Institutional Edge (2โ€“2 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Stryker Corporation (SYK) driven by superior Growth & Margin, Options & Structure while PHG counters with relative strength in Valuation, Momentum & Technical. Fundamentally, SYK trades at 19.0x Forward P/E with 24.0% operating margin (+7.6% YoY revenue) versus PHG at 14.9x Forward P/E and 8.8% operating margin (+2.1% YoY). In options structure, SYK sits in SURGE (5th %ile IV; Dealer Gamma Walls on Pro) against PHG sits in SURGE (2nd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner PHG
SYK 19.0x vs PHG 14.9x Fwd P/E
Growth & Margin Winner SYK
Op Margin 24.0% vs 8.8% ยท YoY +7.6% vs +2.1%
Momentum & Technical Winner PHG
1Y -16.8% vs +4.5% ยท 52W Pos 36% vs 67%
Options & Structure Winner SYK
SURGE (5th %ile IV) vs SURGE (2nd %ile IV)
SYK NYSE
Stryker Corporation
Surgical & Medical Instruments & Apparatus
$310.79
+0.37% 1D
Market Cap $118.9B
1M Return +5.47%
1Y Return -16.77%
Forward P/E 19.0x
Unified AI Score
46.5 / 100 HOLD
Tech 37.0 Fund 49.0 Flow 58.0 Mom 60.0
PHG NYSE
Koninklijke Philips N.V.
X-Ray Apparatus & Tubes & Related Irradiation Apparatus
$30.21
-0.43% 1D
Market Cap $29.6B
1M Return +17.37%
1Y Return +4.46%
Forward P/E 14.9x
Unified AI Score
28.4 / 100 SELL
Tech 50.0 Fund 23.0 Flow 54.0 Mom 11.1

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SYK -16.77% PHG +4.46% Spread: +21.23 pp (PHG Lead)

Pillar 3 Annualized Quarterly Run-Rate Revenue & Operating Margin Trajectory (USD-Normalized)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period SYK Revenue PHG Revenue SYK Op. Margin PHG Op. Margin Margin Edge
Q3 '25 $24.2B $8.44B 19.9% 7.7% SYK
Q4 '25 $28.7B $10.0B 25.3% 11.1% SYK
Q1 '26 $24.1B $7.66B 15.5% 6.2% SYK
Q2 '26 $26.4B $8.55B 25.2% 14.0% SYK
Q3 '26 $26.1B $8.62B 20.4% 3.8% SYK

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SYK (7) vs PHG (3)
Institutional Metric SYK PHG Criterion Row Winner
Market Capitalization Scale $118.9B $29.6B Larger Scale SYK
Trailing P/E Ratio Valuation 33.3x 63.2x Lower Multiple SYK
Forward P/E Ratio Valuation 19.0x 14.9x Lower Multiple PHG
Revenue Growth (YoY) Growth +7.6% +2.1% Higher Growth SYK
Operating Margin (TTM) Profitability 24.0% 8.8% Higher Margin SYK
Net Profit Margin Profitability 13.8% 5.4% Higher Margin SYK
Return on Equity (ROE) Capital Efficiency 16.0% 8.6% Higher ROE SYK
52-Week Range Position Momentum 36% ($267โ€“$389) 67% ($24โ€“$33) Stronger Trend PHG
Beta / 30D Volatility Risk Regime 0.22ฮฒ ยท 50% Vol 0.73ฮฒ ยท 38% Vol Lower Realized Risk PHG
Unified Institutional Score Composite Signal 46.5 / 100 (HOLD) 28.4 / 100 (SELL) Higher Composite SYK

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SYK vs PHG Buy Guide
SYK SURGE
8d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 5th %ile
IV Regime Compressed (<25th %ile)
Live SYK Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PHG SURGE
8d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 2nd %ile
IV Regime Compressed (<25th %ile)
Live PHG Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SYK nor PHG registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.